Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects.
about
A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individualsFish oil and the management of hypertriglyceridemia.Comparison of the Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on the Eradication of Helicobacter pylori Infection, Serum Inflammatory Factors and Total Antioxidant Capacity.Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review.Comparison of the Effects of Eicosapentaenoic Acid With Docosahexaenoic Acid on the Level of Serum Lipoproteins in Helicobacter pylori: A Randomized Clinical Trial(n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?Association between the docosahexaenoic acid to arachidonic acid ratio and acute coronary syndrome: a multicenter observational study.Impact of oil used by the frying industry on population fat intake.Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome.Atherosclerosis, dyslipidemia, and inflammation: the significant role of polyunsaturated Fatty acidsAre the health benefits of fish oils limited by products of oxidation?The differential effects of EPA and DHA on cardiovascular risk factors.Similarities and differences between the effects of EPA and DHA on markers of atherosclerosis in human subjects.The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials.Fish oil omega-3 fatty acids and cardio-metabolic health, alone or with statins.Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia.Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic OverviewOmega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.Intervention with fish oil, but not with docosahexaenoic acid, results in lower levels of hepatic soluble epoxide hydrolase with time in apoE knockout mice.Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels.Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials.The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review.An Improvement of Cardiovascular Risk Factors by Omega-3 Polyunsaturated Fatty Acids.Co-supplementation of healthy women with fish oil and evening primrose oil increases plasma docosahexaenoic acid, gamma-linolenic acid and dihomo-gamma-linolenic acid levels without reducing arachidonic acid concentrations.
P2860
Q26863499-32D4D73E-BF1A-493C-B200-D246BA158D67Q34016763-7D329EE1-2883-4FDA-B44B-CD5AE01A190FQ34777760-99308763-2823-4AFD-864F-01A9FD4969A0Q35094813-44A6DED7-B2C8-4C75-903F-DE1C98A2A3A6Q35124311-76E46DC4-C473-41FB-83D2-4DC3755ED0E0Q35753222-554ED752-9FD8-4396-9AB5-1BE0FD7EC4D8Q36069778-F8EED834-A562-455D-ABE5-3B9610808E70Q36799496-359D0A49-6855-478C-AE2F-4AB24F2CE317Q37024566-F467D752-112B-4438-B05A-0B9207FC2368Q37156857-F22CA6FE-97D6-4981-95CC-E42A93294D12Q37350002-B250955D-976D-45C0-96AF-551C498478C2Q37846894-412063E9-EE57-4AFC-975D-818AE4987EEEQ37988638-F774B694-C796-4194-A4A8-00A5973E1EA1Q38010557-B82082A4-6277-44DA-8B72-108119CF247EQ38081054-12486C1C-73E5-4B49-A35B-CCC3AD968608Q38260532-F5C2DCCF-D6D8-4528-99A4-3281302FCC00Q39427274-880D4888-0C8B-4A57-9CE9-ACDCC81DF253Q41363466-FB2D5938-ED53-408B-AB94-5452DAD0051EQ43293010-84712C03-396F-4FA5-9144-7DB08186F575Q46918945-9A54141E-2E1A-4C92-B41F-518C685DA671Q48181231-8FF189F4-6A20-4E63-B7E3-62F63F23857EQ50099570-880C0694-9EE3-4ABA-A294-CA68E7689BC9Q51743688-DEFF2D03-C5B2-42DA-BFD8-A4B053C69F8FQ53536263-64C81B25-8021-4AED-BDBD-9978CECB5D21
P2860
Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Circulating triacylglycerol an ...... ation in adult human subjects.
@en
Circulating triacylglycerol an ...... ation in adult human subjects.
@nl
type
label
Circulating triacylglycerol an ...... ation in adult human subjects.
@en
Circulating triacylglycerol an ...... ation in adult human subjects.
@nl
prefLabel
Circulating triacylglycerol an ...... ation in adult human subjects.
@en
Circulating triacylglycerol an ...... ation in adult human subjects.
@nl
P2093
P2860
P356
P1476
Circulating triacylglycerol an ...... ation in adult human subjects.
@en
P2093
Anne M Minihane
Bethan Shewring
Parveen Yaqoob
Richard Buckley
Rufus Turner
P2860
P304
P356
10.1079/BJN20041235
P577
2004-09-01T00:00:00Z